Company Description
International Flavors & Fragrances, Inc. engages in the manufacture and supply of flavors and fragrances used in the food, beverage, personal care, and household products industries. It operates through the following segments: Nourish, Health & Biosciences, Scent and Pharma Solutions. The Nourish se...
International Flavors & Fragrances, Inc. engages in the manufacture and supply of flavors and fragrances used in the food, beverage, personal care, and household products industries. It operates through the following segments: Nourish, Health & Biosciences, Scent and Pharma Solutions. The Nourish segment consists of legacy Taste segment combined with N&B's Food & Beverage division and the food protection business of N&B's Health & Biosciences division. The Health & Biosciences business consists of a biotechnology-driven portfolio of enzymes, food cultures, probiotics and specialty ingredients for food, home and personal care, and health and wellness applications. The Scent business creates fragrance compounds, fragrance ingredients and cosmetic ingredients that are integral elements in the world’s finest perfumes and best-known household and personal care products. The Pharma Solutions business produces a vast portfolio including cellulosics and seaweed-based pharma excipients, used to improve the functionality and delivery of active pharmaceutical ingredients, including controlled or modified drug release formulations, and enabling. The company was founded in 1833 and is headquartered in New York, NY.
Valuation
Price to Sales Ratio
2.15
Price to Book Ratio
1.51
Price to Cash Flow Ratio
67.34
Enterprise Value to EBITDA
13.52
Enterprise Value to Sales
2.57
Total Debt to Enterprise Value
0.31
Efficiency
Revenue/Employee
505,691.00
Income Per Employee
-75,935.00
Receivables Turnover
5.69
Total Asset Turnover
0.33
Liquidity
Current Ratio
1.99
Quick Ratio
1.15
Cash Ratio
0.13
Profitability
Gross Margin
27.52
Operating Margin
9.22
Pretax Margin
-13.06
Net Margin
-15.02
Return on Assets
-4.98
Return on Equity
-9.64
Return on Total Capital
3.65
Return on Invested Capital
-6.11
Capital Structure
Total Debt to Total Equity
65.81
Total Debt to Total Capital
39.69
Total Debt to Total Assets
32.87
Long-Term Debt to Equity
61.92
Long-Term Debt to Total Capital
37.34
Officers and Executives
Name | Age | Officer Since | Title |
---|---|---|---|
Dr. Roger Walton Ferguson | 69 | 2010 | Independent Director |
Mr. Franklin K. Clyburn | 56 | 2022 | Chief Executive Officer & Director |
Mr. Glenn Robert Richter | 59 | 2021 | Chief Financial Officer & Executive Vice President |
Mr. Vic Verma | 53 | 2016 | Chief Information Officer & Senior Vice President |
Insider Actions
05/04/2023 |
Christina A. Gold Director |
1,245 | Derivative/Non-derivative trans. at $0 per share. | 0 |
05/04/2023 |
Barry A. Bruno Director |
1,245 | Derivative/Non-derivative trans. at $0 per share. | 0 |
05/04/2023 |
Mark J. Costa Director |
468 | Derivative/Non-derivative trans. at $0 per share. | 0 |
05/04/2023 |
Dawn C. Willoughby Director |
434 | Derivative/Non-derivative trans. at $0 per share. | 0 |
05/04/2023 |
Gaoxiang Hu Director |
434 | Derivative/Non-derivative trans. at $0 per share. | 0 |
05/04/2023 |
Kevin O'Byrne Director |
262 | Derivative/Non-derivative trans. at $0 per share. | 0 |
04/06/2023 |
Christophe de Villeplee President, Scent |
913 | Derivative/Non-derivative trans. at $0 per share. | 0 |
04/06/2023 |
Christophe de Villeplee President, Scent |
1,188 | Derivative/Non-derivative trans. at $0 per share. | 0 |
04/06/2023 |
Gregory Yep EVP, Chief Scientific Officer |
2,665 | Derivative/Non-derivative trans. at $0 per share. | 0 |
04/06/2023 |
Gregory Yep EVP, Chief Scientific Officer |
733 | Derivative/Non-derivative trans. at $91.45 per share. | 67,032 |
04/01/2023 |
Simon W. Herriott President Health & Biosciences |
461 | Derivative/Non-derivative trans. at $90.6 per share. | 41,766 |
04/01/2023 |
Simon W. Herriott President Health & Biosciences |
1,489 | Derivative/Non-derivative trans. at $0 per share. | 0 |
03/01/2023 |
Franklin K. Clyburn Chief Executive Officer |
477 | Derivative/Non-derivative trans. at $91.64 per share. | 43,712 |
03/01/2023 |
Franklin K. Clyburn Chief Executive Officer |
1,323 | Derivative/Non-derivative trans. at $0 per share. | 0 |
02/19/2023 |
Simon W. Herriott President Health & Biosciences |
177 | Derivative/Non-derivative trans. at $96.13 per share. | 17,015 |
02/19/2023 |
Angela Strzelecki President, Pharma Solutions |
176 | Derivative/Non-derivative trans. at $96.13 per share. | 16,918 |
02/19/2023 |
Jennifer A. Johnson EVP, General Counsel |
293 | Derivative/Non-derivative trans. at $96.13 per share. | 28,166 |
02/19/2023 |
Simon W. Herriott President Health & Biosciences |
617 | Derivative/Non-derivative trans. at $0 per share. | 0 |
02/19/2023 |
Angela Strzelecki President, Pharma Solutions |
584 | Derivative/Non-derivative trans. at $0 per share. | 0 |
02/19/2023 |
Jennifer A. Johnson EVP, General Counsel |
708 | Derivative/Non-derivative trans. at $0 per share. | 0 |
01/24/2023 |
Michael L. Ducker Director |
2,210 | Derivative/Non-derivative trans. at $0 per share. | 0 |
01/03/2023 |
Francisco Fortanet EVP, Operations |
2,229 | Derivative/Non-derivative trans. at $103.11 per share. | 229,832 |
01/03/2023 |
Angela Strzelecki President, Pharma Solutions |
487 | Derivative/Non-derivative trans. at $105.64 per share. | 51,446 |
01/03/2023 |
Francisco Fortanet EVP, Operations |
5,254 | Derivative/Non-derivative trans. at $0 per share. | 0 |
01/03/2023 |
Christophe de Villeplee President, Scent |
784 | Derivative/Non-derivative trans. at $0 per share. | 0 |
01/03/2023 |
Angela Strzelecki President, Pharma Solutions |
1,341 | Derivative/Non-derivative trans. at $0 per share. | 0 |
11/01/2022 |
Jennifer A. Johnson EVP, General Counsel |
376 | Derivative/Non-derivative trans. at $95.45 per share. | 35,889 |
11/01/2022 |
Jennifer A. Johnson EVP, General Counsel |
1,041 | Derivative/Non-derivative trans. at $0 per share. | 0 |
10/03/2022 |
Glenn Robert Richter CFO |
11,812 | Derivative/Non-derivative trans. at $0 per share. | 0 |
08/11/2022 |
Francisco Fortanet EVP, Operations |
10,000 | Disposition at $125 per share. | 1,250,000 |
MarketWatch News on IFF
-
International Flavors & Fragrances Inc. stock rises Wednesday, outperforms market
- MarketWatch Automation
-
International Flavors & Fragrances Inc. stock rises Tuesday, outperforms market
- MarketWatch Automation
-
International Flavors & Fragrances Inc. stock falls Monday, underperforms market
- MarketWatch Automation
-
International Flavors & Fragrances Inc. stock outperforms competitors on strong trading day
- MarketWatch Automation
-
International Flavors & Fragrances Inc. stock falls Thursday, underperforms market
- MarketWatch Automation
-
International Flavors & Fragrances Inc. stock falls Wednesday, underperforms market
- MarketWatch Automation
-
International Flavors & Fragrances Inc. stock outperforms competitors despite losses on the day
- MarketWatch Automation
-
International Flavors & Fragrances Inc. stock remains steady Friday, underperforms market
- MarketWatch Automation
-
International Flavors & Fragrances Inc. stock falls Thursday, underperforms market
- MarketWatch Automation
-
International Flavors & Fragrances Inc. stock falls Wednesday, underperforms market
- MarketWatch Automation
-
International Flavors & Fragrances Inc. stock outperforms market despite losses on the day
- MarketWatch Automation
-
International Flavors & Fragrances Inc. stock outperforms competitors despite losses on the day
- MarketWatch Automation
-
International Flavors & Fragrances Inc. stock falls Friday, underperforms market
- MarketWatch Automation
-
International Flavors & Fragrances Inc. stock outperforms competitors on strong trading day
- MarketWatch Automation
-
International Flavors & Fragrances Inc. stock rises Wednesday, outperforms market
- MarketWatch Automation
-
International Flavors & Fragrances Inc. stock underperforms Tuesday when compared to competitors
- MarketWatch Automation
-
International Flavors & Fragrances Inc. stock rises Monday, outperforms market
- MarketWatch Automation
-
International Flavors & Fragrances Inc. stock underperforms Friday when compared to competitors
- MarketWatch Automation
-
International Flavors & Fragrances Inc. stock falls Thursday, underperforms market
- MarketWatch Automation
-
International Flavors & Fragrances Inc. stock underperforms Wednesday when compared to competitors
- MarketWatch Automation
- Loading more headlines...
Other News on IFF
-
10-Q: INTERNATIONAL FLAVORS & FRAGRANCES INC
- Edgar Online - (EDG = 10Q, 10K)
-
Bestinver's 4th-Quarter Letter
- GuruFocus.com
-
Top 5 4th Quarter Trades of First Pacific Advisors
- GuruFocus.com
-
Daniel Loeb Buys AIG, Adds to Bath & Body Works Stake
- GuruFocus.com
-
Top 5 4th Quarter Trades of Daniel Loeb
- GuruFocus.com
-
Top 5 4th Quarter Trades of First Pacific Advisors
- GuruFocus.com
-
Top 5 4th Quarter Trades of WEIK CAPITAL MANAGEMENT
- GuruFocus.com
-
Top 5 4th Quarter Trades of FRONT BARNETT ASSOCIATES LLC
- GuruFocus.com
-
Robert Olstein Buys 3, Sells 2 in 4th Quarter
- GuruFocus.com
-
Top 5 4th Quarter Trades of Searle & Co.
- GuruFocus.com
-
Top 5 4th Quarter Trades of Heathbridge Capital Management Ltd.
- GuruFocus.com
-
Bestinfond's Top 4th-Quarter International Buys
- GuruFocus.com
-
Top 5 4th Quarter Trades of Sarasin & Partners LLP
- GuruFocus.com
-
Top 5 4th Quarter Trades of ZWJ INVESTMENT COUNSEL INC
- GuruFocus.com
- Loading more headlines...